New airway device may reduce breathing risks during ERCP

NCT ID NCT07182786

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether a special airway device called LMA Gastro can prevent high carbon dioxide levels (hypercarbia) in patients undergoing ERCP, a procedure to examine the bile and pancreatic ducts. Fifty adults aged 20-45 with mild to moderate health risks participated. The device combines a breathing tube with a channel for the endoscope, aiming to keep the airway open and reduce breathing complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
LMA Gastro device
What this could lead to
If it works, this device could offer a safer, less invasive way to manage breathing during ERCP, reducing the risk of high CO2 levels.
What could go wrong
This is a small, early-stage study with only 50 participants. Results may not apply to all patients, and the device may not prevent hypercarbia better than standard methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA AIRWAY MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypercapnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Theodor Bilharz Research Institute

    Giza, 12411, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.